VistaShares Animal Spirits 2x Daily Strategy ETF (WILD) to Close

(NYSE Arca:WILD), NEW YORK, Dec. 31, 2025 (GLOBE NEWSWIRE) — VistaShares and Tidal Financial Group announce the planned closure and liquidation of the VistaShares Animal Spirits(TM) 2x Daily Strategy ETF (NYSE: WILD). This decision follows a review of the fund's viability and was made in the best interests of shareholders. The fund will be delisted […]

Western Forest Products Inc. Announces Release Date of Fourth Quarter 2025 Results and Conference Call Details

(TSX:WEF),(TSX:WEF.TO), VANCOUVER, British Columbia, Dec. 31, 2025 (GLOBE NEWSWIRE) — Western Forest Products Inc. (TSX: WEF) (“Western” or the “Company”) fourth quarter 2025 financial and operating results will be released on Tuesday, February 10, 2026. Western will host its fourth quarter 2025 analyst conference call on Wednesday, February 11, 2026 at 9:00 a.m. PST (12:00

Alvotech Secures Term Loan Facility of USD 100 Million

(NasdaqGM:ALVO),(Nasdaq First North Iceland:ALVO),(Stockholm:ALVO SDB), USD 100 million senior term loan facility with a 2-year maturity Strengthens liquidity to support execution across Alvotech's R&D pipeline and global product launches through 2026 Led by GoldenTree Asset Management REYKJAVIK, Iceland, Dec. 31, 2025 (GLOBE NEWSWIRE) — Alvotech (NASDAQ: ALVO), a global biotechnology company specializing in the development

Rubico Inc. Announces Acquisition of Newbuilding Mega Yacht

(NASDAQ:RUBI), ATHENS, Greece, Dec. 31, 2025 (GLOBE NEWSWIRE) — Rubico Inc. (Nasdaq: RUBI) (the “Company” or “Rubico”), a global provider of shipping transportation services specializing in the ownership of vessels, announced today that it has entered into a purchase agreement (the “SPA”) for the acquisition from Top Ships Inc. of a vessel-owning company (the “Owner”)

PLATINUM EQUITY COMPLETES ACQUISITION OF OWENS & MINOR PRODUCTS & HEALTHCARE SERVICES BUSINESS

P&HS anticipated to benefit from Platinum's carve-out experience, sector expertise and commitment to growing the business P&HS will retain Owens & Minor brand and operate as a standalone company in Platinum's portfolio Platinum Equity announced today that the acquisition of the Owens & Minor Products & Healthcare Services business (“Owens & Minor P&HS”) has been

ROSEN, A LONGSTANDING LAW FIRM, Encourages Alexandria Real Estate Equities, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ARE

(NYSE:ARE), NEW YORK, Dec. 31, 2025 (GLOBE NEWSWIRE) — WHY: New York, N.Y., December 31, 2025. Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Alexandria Real Estate Equities, Inc. (NYSE: ARE) between January 27, 2025 and October 27, 2025, both dates inclusive (the “Class Period”) of the important January

Shareholders that lost money on Klarna Group plc(KLAR) Urged to Join Class Action – Contact The Gross Law Firm to Learn More

(NYSE:KLAR), NEW YORK, Dec. 31, 2025 (GLOBE NEWSWIRE) — The Gross Law Firm issues the following notice to shareholders of Klarna Group plc (NYSE: KLAR). Shareholders who purchased shares of KLAR during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to

The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Coupang, Inc.(CPNG) Shareholders

(NYSE:CPNG), NEW YORK, Dec. 31, 2025 (GLOBE NEWSWIRE) — The Gross Law Firm issues the following notice to shareholders of Coupang, Inc. (NYSE: CPNG). Shareholders who purchased shares of CPNG during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of February 17, 2026 in SLM Corporation Lawsuit – SLM

(NASDAQ:SLM), NEW YORK, Dec. 31, 2025 (GLOBE NEWSWIRE) — The Gross Law Firm issues the following notice to shareholders of SLM Corporation (NASDAQ: SLM). Shareholders who purchased shares of SLM during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake

Outlook Therapeutics Provides Regulatory Update on U.S. Food and Drug Administration Review of ONS-5010/LYTENAVA(TM) (bevacizumab-vikg) for the Treatment of Wet AMD

(NASDAQ:OTLK),(NASDAQ:OTLKW), ISELIN, N.J., Dec. 31, 2025 (GLOBE NEWSWIRE) — Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the treatment of retina diseases, today announced that the U.S. Food and Drug Administration (FDA) has issued a complete response letter (CRL) to the ONS-5010/LYTENAVA(TM) (bevacizumab-vikg) biologics license

Scroll to Top